Evidence map›Paper›PMID 39189761›Full record

Trial reportMicrobiology spectrum2024

Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults.

Madhur Wyatt, Ankan Choudhury, Gabriella Von Dohlen, Jeffery L Heileson, Jeffrey S Forsse, Sumudu Rajakaruna, Manja Zec, Malak M Tfaily, Leigh Greathouse

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. The Role of Vitamin D in Gastrointestinal Homeostasis and Gut Inflammation.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Madhur WyattHuman Health Performance and Recreation, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.ORCID 0009-0000-7007-365X
Ankan ChoudhuryHuman Science and Design, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.
Gabriella Von DohlenHuman Science and Design, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.
Jeffery L HeilesonHuman Health Performance and Recreation, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.
Jeffrey S ForsseHuman Health Performance and Recreation, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.
Sumudu RajakarunaDepartment of Environmental Science, University of Arizona, Tucson, Arizona, USA.
Manja ZecDepartment of Environmental Science, University of Arizona, Tucson, Arizona, USA.
Malak M TfailyDepartment of Environmental Science, University of Arizona, Tucson, Arizona, USA.
Leigh GreathouseHuman Science and Design, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.ORCID 0000-0002-6855-8516

Funding

Baylor University (BU) N/AU.S. Department of Energy (DOE) DE-SC0021349
6 · The paper itself

Abstract

Evidence indicates that both vitamin D and the gut microbiome are involved in the process of colon carcinogenesis. However, it is unclear what effects supplemental vitamin D IMPORTANCE: Preventative measures to reduce the rise in early-onset colorectal cancer are of critical need. Both vitamin D, dietary and serum levels, and the gut microbiome are implicated in the etiology of colorectal cancer. By understanding the intimate relationship between vitamin D, the gut microbiome, and its metabolites, we may be able to identify key mechanisms that can be targeted for intervention, including inflammation and metabolic dysfunction. Furthermore, the similarity of vitamin D to cholesterol, which is metabolized by the gut microbiome, gives precedence to its ability to produce metabolites that can be further studied and leveraged for controlling colorectal cancer incidence and mortality.

Indexed as

Dietary SupplementsGastrointestinal MicrobiomeVitamin DAdultBacteriaCholecalciferolDouble-Blind MethodFecesFemaleHealthy VolunteersHumansMaleMiddle AgedYoung Adult25-hydroxyvitamin DCholecalciferolVitamin Dcolon cancerearly-onset colorectal cancergut microbiomeinflammationmicrobiome stabilityvitamin D

Identifiers

PMID39189761
PMCPMC11448053

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.